Skip to main content
Fig. 5 | Cancer Nanotechnology

Fig. 5

From: Targeted inhibition of gastric cancer progression via a chitosan-RNU11 siRNA nanoparticle delivery system: mechanistic insights and therapeutic potential

Fig. 5

Effects of chitosan-RNU11 siRNA drug delivery system on the development of HGC27 cell. A Cell viability assay; B cell cycle detection; C detection of apoptosis-related proteins; D cell proliferation number detection; E cell scratch healing rate detection; FG cell invasion and migration number detection; H cell apoptosis rate detection

Back to article page